PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
28-Jan-2022 Generis appoints Head of Life Sciences as CARA™ growth soars Generis
28-Jan-2022 Thermo Fisher Scientific Earns Top Score for LGBTQ+ Workplace Equality for Seventh Consecutive Year Thermo Fisher Scientific
28-Jan-2022 Original-Research: HAEMATO AG (von GBC AG) HAEMATO AG
28-Jan-2022 atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments atai Life Sciences
28-Jan-2022 Orgenesis reaches next milestone in collaboration with Hospital Infantil Universitario Niño Jesús in Madrid Orgenesis Inc.
28-Jan-2022 Novel data in Alzstatin Alzheimer’s project presented at the 11th Pharmaceutical Profiling meeting AlzeCure Pharma AB
28-Jan-2022 4D pharma announces additional positive data from Part A of the Phase I/II trial of MRx-4DP0004 for the treatment of asthma 4D pharma
28-Jan-2022 Key figures for 2021 financial year: COLTENE delivers excellent full-year results thanks to strong demand COLTENE Holding AG
27-Jan-2022 PharmiWeb.Jobs Welcomes Global Life Science Hub PharmiWeb.Jobs
27-Jan-2022 Gerresheimer AG: The leading supplier of injection vials Gerresheimer expands production in Wertheim Gerresheimer AG
27-Jan-2022 PAION AG ANNOUNCES CHANGE IN SUPERVISORY BOARD PAION AG
27-Jan-2022 CONDOR project for precision medicine and sarcoma immunotherapy awarded close to €10M in the fifth call for Hospital-University Research in Health (RHU) projects Andrew Lloyd Associates
27-Jan-2022 SiSaf Announces Michael J. Econs MD, World-leading Expert in Metabolic Bone Disease, as Clinical Advisor SiSaf Ltd
27-Jan-2022 New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System Aptar Pharma
27-Jan-2022 Alfa Chemistry Now Offers Pharmaceutical and Drug Standards Alfa Chemistry
27-Jan-2022 Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from Right to Try Use of Aviptadil During Omicron Surge RELIEF THERAPEUTICS Holding AG
27-Jan-2022 Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences RELIEF THERAPEUTICS Holding AG
27-Jan-2022 HOW HAS COVID-19 IMPACTED PATIENT USE OF DIGITAL TOOLS & DISEASE CONTROL? Bryter
26-Jan-2022 RAIN Group Releases New Guide “36 Powerful Sales Questions for Life Sciences” RAIN Group
26-Jan-2022 Queen’s University Belfast enters collaboration and licensing agreement with Ipsen to progress FLIP inhibitor project which has been supported by Domainex Domainex